So, comps that are working on improved *UNIVERSAL* flu vaccines may benefit next year. Any idea?
My guess is that likely 90%+ of every company with a covid-program in it's pipeline would claim to also be working on influenza programs among various others.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.